Johnson & Johnson’s pharmaceuticals subsidiary Janssen is walking away from plans to launch an HIV vaccine in the immediate future after the data safety monitoring board...

In its third fundraising round in less than two years, Hong Kong-listed globally active CDMO giant GenScript Biotech has netted a fresh $224 million capital injection...

Johnson & Johnson is finally pulling the plug on its iconic talc-based baby powder worldwide.

US health authorities are restricting the use of the Johnson & Johnson Covid vaccine somewhat belatedly, citing the rare blood clotting issues that have dogged this...

US healthcare giant Johnson & Johnson and three major distributors, AmerisourceBergen, Cardinal Health and McKesson, have finalized a long-negotiated nationwide...

As wealthy countries with ample supplies of Covid-19 vaccine struggle to convince more people to get the shot, and poorer countries struggle to nail down supplies, two US...

Another US healthcare business is being split into separate parts or separated from other parts of a diverse group. First General Electric, with its health segment, went...

South Africa's Aspen Pharmacare aims to ramp up its Covid-19 vaccine manufacturing capacity to 1.3 billion doses per year by February 2024, from 250 to 300 million doses...